Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)

David Cibula,Simone Marnitz,Jaroslav Klat,Jiri Jarkovsky,Giampaolo Di Martino,Luc Van Lonkhuijzen,Ignacio Zapardiel,Michal Zikan,Octavio Arencibia Sanchez,Francesco Raspagliesi,Jiri Presl,Lubos Minar,Ariel Gustavo Glickman,Marcela Ostojich,Almerinda Petiz,Špela Smrkolj,Toon Van Gorp,Roman Kocián,Kristyna Nemejcova,Christhardt Köhler

doi:10.1016/j.ygyno.2024.07.028

Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)

David Cibula, Simone Marnitz + Show 18 more

https://doi.org/10.1016/j.ygyno.2024.07.028

Copy DOI

Export

Save

Cite

Journal: Gynecologic Oncology

Publication Date: Nov 1, 2024

#Systematic Pelvic Lymphadenectomy #Sentinel Lymph Node Biopsy #Early-stage Cervical Cancer #International Trial #Survival Of Patients #Systematic Lymphadenectomy #Primary Endpoint Outcome #Sentinel Lymph Node #Lymph Node Biopsy #Endpoint Outcome

Abstract
Full-Text
Similar Papers

Abstract

Listen

Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Gynecologic Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)